Compare MWH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MWH | LNTH |
|---|---|---|
| Founded | 2008 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.3B |
| IPO Year | N/A | 2014 |
| Metric | MWH | LNTH |
|---|---|---|
| Price | $37.61 | $82.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | $35.42 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 724.3K | 612.4K |
| Earning Date | 03-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.41 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $51.86 | N/A |
| Revenue Next Year | $14.78 | $14.19 |
| P/E Ratio | $50.60 | ★ $24.23 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $26.60 | $47.27 |
| 52 Week High | $36.76 | $108.86 |
| Indicator | MWH | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 74.07 | 59.50 |
| Support Level | $27.32 | $72.35 |
| Resistance Level | N/A | $84.77 |
| Average True Range (ATR) | 1.68 | 2.11 |
| MACD | 0.69 | 0.10 |
| Stochastic Oscillator | 93.22 | 76.01 |
SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.